Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Biotech Stocks That Could Soar This Year

TheMotleyFool

0 0

2 Biotech Stocks That Could Soar This YearPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

While it's difficult to predict how the market -- or individual companies -- will perform over the course of 12 months, there can be signs that allow us to make educated guesses. Take, for instance, CRISPR Therapeutics (NASDAQ: CRSP) and Summit Therapeutics (NASDAQ: SMMT). These are two companies that belong to the volatile biotech industry, and both have catalysts on the horizon that could lead to strong performances in 2026.

Let's look deeper to figure out whether CRISPR Therapeutics and Summit Therapeutics are worth investing in this year.

Image source: Getty Images.

Source Fool.com

Like: 0

CRSP

Share